Cannabis industry data insights provided by BDS Analytics’ July 2019 report reveals that medical marijuana sales in Arizona increased by 26% compared to July 2018.
The report discloses category-specific Arizona medical marijuana industry sales data, as NCV Newswire reported:
Sales for Arizona’s medical dispensaries were $61 million this past July, an eight percent increase from June 2019. Compared to July 2018, sales increased by 26 percent. Year-to-date sales increased by 15 percent compared the same period in 2018, reaching $394.6 million.
In July, the $26.4 million in sales from Flower contributed 43 percent towards overall revenues for the month. Flower sales increased by 11 percent from the trailing month and 22 percent from the year prior. Year-to-date, Flower sales have increased six percent, reaching $165.6 million.
Pre-Rolled Joints remain a small category in Arizona’s medical-only market. Sales of Pre-Rolled Joints were $2.1 million in July and $14.2 million in the first seven months of 2019. Compared to 2018, sales for the month increased 18 percent and year-to-date sales increased nine percent. In the most recent reporting period, the category contributed three percent towards overall revenues.
The Concentrates product category contributed 39 percent towards overall revenues in July. The $23.9 million in Concentrates sales represented 28 percent growth compared to July 2018. In the first seven months of 2019, Concentrates sales increased 21 percent compared to the same period last year, reaching $154.8 million. Concentrates sales are segmented into Dabbable and Vape products. Compared to July 2018, sales increased 19 and 33 percent for the two categories, respectively.
Sales of Ingestibles generated $7.1 million in sales in July 2019 and contributed 12 percent towards total revenues for the month. Compared to July 2018, sales increased over 34 percent. Year-to-date, the $49.7 million sold in Ingestibles was 31 percent greater compared to the same period in 2018. The Ingestibles category includes both the Edible and Sublingual subcategories. Edibles sales contributed 85 percent towards Ingestibles revenues in July and sales increased 31 percent compared to July 2018. Sales of Sublinguals in July 2019 have increased 57 percent compared to July 2018.